(PSYCHIATRIC TIMES) - MedPage Today Action Points
SAN DIEGO, May 24 -- Pharmacotherapy for schizophrenia may be better than it's ever been, but it's not nearly good enough.
In a nationwide survey of psychiatrists, 95% said that there is a need for new, highly effective drug options, said Peter Buckley, M.D., of the Medical College of Georgia.
About the same percentage of respondents said that their patients would directly benefit from such therapies, said Dr. Buckley at an industry-funded symposium presented in conjunction with the American Psychiatric Association meeting here.
The survey, conducted by Harris Interactive and commissioned by Janssen, polled psychiatrists who work in a wide variety of clinical settings-hospitals, community health centers, private practice, correctional facilities, nursing homes, and others.
For full article, please visit: